| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.054 | 0.08 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |